Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela Shaw

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Respiratory function, survival, and NIV prevalence over time in ALS - a PRECISION ALS studyStefan Sennfält, Ammar Al-Chalabi, Alejandro Caravaca Puchades, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Examining changing working status and caregiver assistance in amyotrophic lateral sclerosis (ALS) using large-scale European databases as part of PRECISION-ALSHarry McDonough, Robert McFarlane, Alejandro Caravaca Puchades, et al.
Molecular Cancer Therapeutics|June 9, 2023
Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody-Drug Conjugate for the Treatment of CancerDorin Toader, Shawn P Fessler, Scott D Collins, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 21, 2025
Neuropsychological assessment practices in PRECISION-ALS: challenges and opportunities for harmonizationEmmet Costello, Joke De Vocht, Emily Beswick, et al.
JAMA Network Open|January 25, 2022
Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19: A Meta-analysisAndrea B Troxel, Eva Petkova, Keith Goldfeld, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 15, 2016
Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALSPatrick Oeckl, Claude Jardel, François Salachas, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 5, 2017
July 2017 ENCALS statement on edaravoneAmmar Al-Chalabi, Peter M Andersen, Siddharthan Chandran, et al.
The Lancet. Neurology|March 13, 2012
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional studyElisa Majounie, Alan E Renton, Kin Mok, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Respiratory function, survival, and NIV prevalence over time in ALS - a PRECISION ALS studyStefan Sennfält, Ammar Al-Chalabi, Alejandro Caravaca Puchades, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Examining changing working status and caregiver assistance in amyotrophic lateral sclerosis (ALS) using large-scale European databases as part of PRECISION-ALSHarry McDonough, Robert McFarlane, Alejandro Caravaca Puchades, et al.
Molecular Cancer Therapeutics|June 9, 2023
Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody-Drug Conjugate for the Treatment of CancerDorin Toader, Shawn P Fessler, Scott D Collins, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 21, 2025
Neuropsychological assessment practices in PRECISION-ALS: challenges and opportunities for harmonizationEmmet Costello, Joke De Vocht, Emily Beswick, et al.
JAMA Network Open|January 25, 2022
Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19: A Meta-analysisAndrea B Troxel, Eva Petkova, Keith Goldfeld, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 15, 2016
Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALSPatrick Oeckl, Claude Jardel, François Salachas, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 5, 2017
July 2017 ENCALS statement on edaravoneAmmar Al-Chalabi, Peter M Andersen, Siddharthan Chandran, et al.
The Lancet. Neurology|March 13, 2012
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional studyElisa Majounie, Alan E Renton, Kin Mok, et al.
Pageof 6